Membrane stabliser - FORMA Therapeutics
Alternative Names: Membrane stabilizer - FORMA TherapeuticsLatest Information Update: 19 Oct 2022
At a glance
- Originator FORMA Therapeutics
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Preclinical Haematological disorders
Most Recent Events
- 14 Oct 2022 FORMA Therapeutics has been acquired by Novo Nordisk
- 28 Jun 2022 Membrane stabliser - FORMA Therapeutics is available for licensing as of 21 Jun 2022. https://www.formatherapeutics.com/pipeline/
- 21 Jun 2022 Preclinical trials in Haematological disorders in USA (unspecified route) before June 2022 (FORMA Therapeutics pipeline, June 2022)